Atlantic Notes: Embiid, Walker, Shamet, Knicks, Raptors

After missing the Sixers‘ last two games prior to the All-Star break due to right knee soreness, center Joel Embiid will remain inactive vs. Atlanta on Thursday, tweets Tim Bontemps of ESPN. While “right knee injury management” is still one of the designations for Embiid on Philadelphia’s injury report, he also experienced some right shin soreness during the All-Star break, according to the team.

Embiid will be reevaluated ahead of the Sixers’ back-to-back set in New Orleans and Minnesota on Saturday and Sunday, so it’s possible he won’t be facing an extended absence. Still, the fact that the big man is out again following a promising stretch in which he appeared in 18 of Philadelphia’s 22 games is a reminder that his health remains a question mark hanging over the club as the second half tips off, writes Tony Jones of The Athletic.

For what it’s worth, head coach Nick Nurse didn’t sound overly concerned when he discussed Embiid’s health after the former MVP took part in Wednesday’s practice.

“He was out there and he looked pretty good,” Nurse said before the 76ers ruled Embiid out for Thursday’s game. “He’s got a meeting shortly with the doctors, and I think we’ll know a little bit more about where he is. But, he was out there a little bit today, and he looked pretty good.”

Here’s more from around the Atlantic:

• Jabari Walker‘s new two-year, minimum-salary contract with the Sixers is partially guaranteed for $250K in 2026/27, tweets Keith Smith of Spotrac. Walker was officially promoted from his two-way deal to Philadelphia’s 15-man roster earlier today.
• Has Landry Shamet been the NBA’s best minimum-salary signing this season? James L. Edwards III of The Athletic suggests that players like Celtics center Neemias Queta and Raptors big man Sandro Mamukelashvili are also in that conversation, but presents the case for the Knicks guard, who has averaged a career-high 9.6 points per game while making 42.2% of his three-pointers.
• James Dolan, the CEO of Madison Square Garden Sports – the parent company of the Knicks and the NHL’s New York Rangers – stated on Wednesday that the company is considering splitting up the two franchises into separate publicly traded companies, per Mike Vorkunov of The Athletic. A source tells Taylor Herzlich of The New York Post that the possibility of separating the two teams isn’t related to a desire to sell either franchise or to take the companies private.
• Michael Grange of Sportsnet.ca considers five factors that could determine the Raptors‘ fate for the rest of the season, starting with the health of center Jakob Poeltl, who has been bothered by back issues all year. The trade sending out Ochai Agbaji earlier this month also means there should be more opportunities available for Toronto’s young wings in the coming weeks, Grange notes.